Hemington Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$714K Sell
937
-9
-1% -$6.7K 0.09% 66
2025
Q2
$737K Sell
946
-39
-4% -$30.3K 0.11% 65
2025
Q1
$813K Buy
985
+124
+14% +$103K 0.13% 59
2024
Q4
$664K Buy
861
+3
+0.3% +$2.48K 0.17% 62
2024
Q3
$711K Sell
858
-33
-4% -$29.7K 0.19% 58
2024
Q2
$806K Buy
891
+46
+5% +$36.8K 0.27% 53
2024
Q1
$658K Buy
845
+43
+5% +$30.6K 0.24% 58
2023
Q4
$468K Sell
802
-32
-4% -$18.7K 0.18% 67
2023
Q3
$447K Sell
834
-168
-17% -$86.6K 0.21% 58
2023
Q2
$469K Sell
1,002
-45
-4% -$18.9K 0.19% 60
2023
Q1
$359K Buy
1,047
+19
+2% +$6.41K 0.14% 72
2022
Q4
$376K Buy
1,028
+17
+2% +$6.03K 0.16% 65
2022
Q3
$327K Buy
1,011
+14
+1% +$4.44K 0.14% 64
2022
Q2
$323K Buy
997
+17
+2% +$5.1K 0.13% 76
2022
Q1
$281K Buy
+980
New +$252K 0.09% 92
2021
Q4
Sell
-989
Closed -$229K 92
2021
Q3
$229K Buy
989
+15
+2% +$3.7K 0.08% 89
2021
Q2
$224K Buy
+974
New +$196K 0.1% 84

Other funds holding LLY

Hemington Wealth Management's LLY Position: Q3 2025 in Review

Hemington Wealth Management reduced its Eli Lilly (LLY) stake by 0.95% in Q3 2025, selling an estimated $6.7K and leaving 937 shares worth $714K. The position accounts for 0.09% of the portfolio, ranked #66.

Hemington Wealth Management first reported a position in LLY in Q2 2021 and has held it in 17 quarters since. The position peaked at $813K in Q1 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Hemington Wealth Management held 937 shares of Eli Lilly worth $714K as of Q3 2025.
  • Hemington Wealth Management sold 9 Eli Lilly shares in Q3 2025, an estimated $6.7K.
  • Eli Lilly made up 0.09% of Hemington Wealth Management's portfolio in Q3 2025, its #66 holding.
  • Hemington Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 17 quarters since.
  • Hemington Wealth Management's Eli Lilly position peaked at $813K in Q1 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.